Terms: = Germ cell tumor AND PDCD1LG2, Q9BQ51, 80380, ENSG00000197646, MGC142240, Btdc, PDCD1L2, CD273, B7DC, MGC142238, PD-L2, PDL2, bA574F11_2
92473 results:
1. Dose escalation study of a personalized peptide-based neoantigen vaccine (EVX-01) in patients with metastatic melanoma.
Mørk SK; Skadborg SK; Albieri B; Draghi A; Bol K; Kadivar M; Westergaard MCW; Stoltenborg Granhøj J; Borch A; Petersen NV; Thuesen N; Rasmussen IS; Andreasen LV; Dohn RB; Yde CW; Noergaard N; Lorentzen T; Soerensen AB; Kleine-Kohlbrecher D; Jespersen A; Christensen D; Kringelum J; Donia M; Hadrup SR; Marie Svane I
J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38782542
[TBL] [Abstract] [Full Text] [Related]
2. [The pathological characteristics and prognostic analysis of medullary thyroid microcarcinoma].
Li DP; Zhang JM; Zhang YH; Hu LF; Gao Y; Wei SF; Zheng XQ
Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1825-1830. PubMed ID: 38782750
[No Abstract] [Full Text] [Related]
3. Vasorin promotes endothelial differentiation of glioma stem cells via stimulating the transcription of VEGFR2.
Qin Z; Zhong Y; Li P; Ma Z; Kang H; Huang Y; Zhong Y; Wang L
FASEB J; 2024 May; 38(10):e23682. PubMed ID: 38780524
[TBL] [Abstract] [Full Text] [Related]
4. Deformable registration of magnetic resonance images using unsupervised deep learning in neuro-/radiation oncology.
Osman AFI; Al-Mugren KS; Tamam NM; Shahine B
Radiat Oncol; 2024 May; 19(1):61. PubMed ID: 38773620
[TBL] [Abstract] [Full Text] [Related]
5. mRNA markers for survival prediction in glioblastoma multiforme patients: a systematic review with bioinformatic analyses.
Azimi P; Yazdanian T; Ahmadiani A
BMC Cancer; 2024 May; 24(1):612. PubMed ID: 38773447
[TBL] [Abstract] [Full Text] [Related]
6. Targeting c-Myc transactivation by LMNA inhibits tRNA processing essential for malate-aspartate shuttle and tumour progression.
Wang J; Hong M; Cheng Y; Wang X; Li D; Chen G; Bao B; Song J; Du X; Yang C; Zheng L; Tong Q
Clin Transl Med; 2024 May; 14(5):e1680. PubMed ID: 38769668
[TBL] [Abstract] [Full Text] [Related]
7. Comparison of two region-of-interest placement methods for histogram analysis of apparent diffusion coefficient maps for glioma grading.
Hieu ND; Hung ND; Hung ND; Hien MM; Anh DV; Dung LT
Clin Ter; 2024; 175(3):128-136. PubMed ID: 38767069
[TBL] [Abstract] [Full Text] [Related]
8. Mortality trend of cutaneous melanoma in Montenegro from 1990-2018.
Nedovic Vukovic M; Terzic Z; Golubovic M; Bojic M; Bukumiric Z
Eur Rev Med Pharmacol Sci; 2024 May; 28(9):3463-3472. PubMed ID: 38766804
[TBL] [Abstract] [Full Text] [Related]
9. Risk factor analysis and nomogram development and verification for medullary carcinoma of the colon using SEER database.
Yang L; Yu L; Zhou Q; Liu L; Shen N; Li N
Sci Rep; 2024 May; 14(1):11426. PubMed ID: 38763982
[TBL] [Abstract] [Full Text] [Related]
10. A longer time to relapse is associated with a larger increase in differences between paired primary and recurrent IDH wild-type glioblastomas at both the transcriptomic and genomic levels.
Ho WM; Chen CY; Chiang TW; Chuang TJ
Acta Neuropathol Commun; 2024 May; 12(1):77. PubMed ID: 38762464
[TBL] [Abstract] [Full Text] [Related]
11. IDH1 mutation produces R-2-hydroxyglutarate (R-2HG) and induces mir-182-5p expression to regulate cell cycle and tumor formation in glioma.
Zhao H; Meng L; Du P; Liao X; Mo X; Gong M; Chen J; Liao Y
Biol Res; 2024 May; 57(1):30. PubMed ID: 38760850
[TBL] [Abstract] [Full Text] [Related]
12. Dual-targeted delivery of temozolomide by multi-responsive nanoplatform via tumor microenvironment modulation for overcoming drug resistance to treat glioblastoma.
Chen X; Zheng Y; Zhang Q; Chen Q; Chen Z; Wu D
J Nanobiotechnology; 2024 May; 22(1):264. PubMed ID: 38760771
[TBL] [Abstract] [Full Text] [Related]
13. Association of lipid-lowering drug targets with risk of cutaneous melanoma: a mendelian randomization study.
Miao L; Miao T; Zhang Y; Hao J
BMC Cancer; 2024 May; 24(1):602. PubMed ID: 38760735
[TBL] [Abstract] [Full Text] [Related]
14. Alkylating agents are possible inducers of glioblastoma and other brain tumors.
Smith CJ; Perfetti TA; Chokshi C; Venugopal C; Ashford JW; Singh SK
Hum Exp Toxicol; 2024; 43():9603271241256598. PubMed ID: 38758727
[TBL] [Abstract] [Full Text] [Related]
15. A clinicopathological study of non-functioning pituitary neuroendocrine tumours using the World Health Organization 2022 classification.
Woo CS; Ho RS; Ho G; Lau HT; Fong CH; Chang JY; Leung EK; Tang LC; Ma IK; Lee AC; Lui DT; Woo YC; Chow WS; Leung GK; Tan KC; Lam KS; Lee CH
Front Endocrinol (Lausanne); 2024; 15():1368944. PubMed ID: 38756997
[TBL] [Abstract] [Full Text] [Related]
16. Multi-omic analysis identifies hypoalbuminemia as independent biomarker of poor outcome upon PD-1 blockade in metastatic melanoma.
Leek LVM; Notohardjo JCL; de Joode K; Velker EL; Haanen JBAG; Suijkerbuijk KPM; Aarts MJB; de Groot JWB; Kapiteijn E; van den Berkmortel FWPJ; Westgeest HM; de Gruijl TD; Retel VP; Cuppen E; van der Veldt AAM; Labots M; Voest EE; van de Haar J; van den Eertwegh AJM
Sci Rep; 2024 May; 14(1):11244. PubMed ID: 38755213
[TBL] [Abstract] [Full Text] [Related]
17. PRESOLRE: study protocol for a primary school-based, cluster randomised controlled trial of three sun exposure risk prevention strategies on Reunion Island.
Dugast C; Bruneau L; Fianu A; Ferdynus C; Boussaid K; Vuichard J; Duloutre F; Dumez J; Sultan-Bichat N; Bertolotti A
BMJ Open; 2024 May; 14(5):e082045. PubMed ID: 38754877
[TBL] [Abstract] [Full Text] [Related]
18. Knockdown of trem2 promotes proinflammatory microglia and inhibits glioma progression via the JAK2/STAT3 and NF-κB pathways.
Yan Y; Bai S; Han H; Dai J; Niu L; Wang H; Dong Q; Yin H; Yuan G; Pan Y
Cell Commun Signal; 2024 May; 22(1):272. PubMed ID: 38750472
[TBL] [Abstract] [Full Text] [Related]
19. Safety and efficacy of peptide receptor radionuclide therapy in neuroendocrine tumors: A single center experience.
Sukrithan V; Armbruster H; Rogers S; Vogt SM; Grenade C; Verschraegen C; Zhou Y; Goyal A; Natwa M; Hussein A; Barr H; Konate D; Batdorf R; Brown A; Williams B; Zhao S; Wei L; Xu M; Shah MH; Konda B
PLoS One; 2024; 19(5):e0298824. PubMed ID: 38748739
[TBL] [Abstract] [Full Text] [Related]
20. Exploring the role of HLA variants in neuroblastoma susceptibility through whole exome sequencing.
Bonfiglio F; Lasorsa VA; Aievola V; Cantalupo S; Morini M; Ardito M; Conte M; Fragola M; Eva A; Corrias MV; Iolascon A; Capasso M
HLA; 2024 May; 103(5):e15515. PubMed ID: 38747019
[TBL] [Abstract] [Full Text] [Related]
[Next]